Prosensa has begun the FDA submission process for its treatment for Duchenne muscular dystrophy, planning to fully file by year’s end with hopes of finally winning approval for a drug that has survived a few brushes with failure.

…read more

Source: Prosensa heads to the FDA with its once-failed DMD treatment


0 No comments